Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 729 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q2
MICHAEL BEST STRATEGIES LLC for AMERICAN KRATOM ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View → Q2
BUCHANAN INGERSOLL & ROONEY PC for UNIVERSITY OF PITTSBURGH MEDICAL CENTER HEALTH PLAN
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $50,000.00 income
Budget/Appropriations, Health Issues, Insurance, Medicare/Medicaid
View → Q2
BUCHANAN INGERSOLL & ROONEY PC for UNIVERSITY OF PITTSBURGH MEDICAL CENTER
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $80,000.00 income
Pharmacy, Medicare/Medicaid, Health Issues, Insurance
View → Q2
BUCHANAN INGERSOLL & ROONEY PC for BIOFLORIDA, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate · $20,000.00 income
Pharmacy, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View → Q2
BOLD STRATEGIES, LLC for MORRIS & DICKSON CO., LLC
2nd Quarter (Apr 1 - June 30) 2026 · Louisiana · House · Senate · $10,000.00 income
Health Issues, Pharmacy
View → Q2
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY
2nd Quarter (Apr 1 - June 30) 2026 · Indiana · House · Senate · $90,000.00 income
Health Issues, Pharmacy
View → Q2
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELANCO ANIMAL HEALTH
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $40,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills)
View → Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View → Q2
THORN RUN PARTNERS for OTSUKA AMERICA PHARMACEUTICAL, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $50,000.00 income
Pharmacy, Health Issues, Taxation/Internal Revenue Code
View → Q2
POLARIS GOVERNMENT RELATIONS, LLC for CIGNA CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Pharmacy
View → Q2
THORN RUN PARTNERS for AMBIOPHARM INC.
2nd Quarter (Apr 1 - June 30) 2026 · South Carolina · House · Senate · $80,000.00 income
Pharmacy, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View → Q2
THE VOGEL GROUP for NEPHRON PHARMACEUTICALS CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · South Carolina · $50,000.00 income
Pharmacy
View → Q2
RADIUS ADVOCACY, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income
Copyright/Patent/Trademark, Pharmacy
View → Q2
RADIUS ADVOCACY, LLC for HEALTHCARE DISTRIBUTION ALLIANCE
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $50,000.00 income
Pharmacy
View → Q2
RADIUS ADVOCACY, LLC for HEALTHCARE DISTRIBUTION ALLIANCE
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · $50,000.00 income
Pharmacy
View → Q2
CHAMBER HILL STRATEGIES for OS THERAPIES
2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate
Pharmacy, Health Issues
View → Q2
THE KPM GROUP DC LLC for THE HS COALITION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy
View → Q2
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View → Q2
TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Defense, Pharmacy, Medicare/Medicaid
View → Q2
H.A. CUMBER & COMPANY, INC. for BAUSCH & LOMB
2nd Quarter (Apr 1 - June 30) 2026 · Florida · $30,000.00 income
Medical/Disease Research/Clinical Labs, Pharmacy
View → Q2
FOLEY & LARDNER LLP for FOUNDATION CONSUMER HEALTHCARE LLC
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $120,000.00 income
Pharmacy, Health Issues
View → Q2
ALPINE GROUP PARTNERS, LLC. for PHRMA
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $50,000.00 income
Health Issues, Government Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View → Q2
FOLEY & LARDNER LLP for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $80,000.00 income
Pharmacy, Trade (domestic/foreign), Manufacturing
View → Q2
CONTINENTAL STRATEGY, LLC for NRX PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · $75,000.00 income
Pharmacy
View → Q2
CONTINENTAL STRATEGY, LLC for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Pharmacy
View →
Previous Page 7 of 30 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem